Functional PAX-6 gene-linked polymorphic region: potential association with paranoid schizophrenia

BACKGROUND Early differentiation of the nervous system and adult CNS neuroplasticity is modulated by PAX-6. We have shown previously that a highly polymorphic, functional AC/AG repeat in the 5' regulatory region of the gene showed significantly increased promoter activity, if containing > or = 29 repeats, and that the heterozygous genotype (< or = 28/> or = 29) revealed increased mRNA PAX-6 levels in human brain tissue compared to the homozygous short variant. METHODS In a case-control study of 655 unrelated individuals, allele frequencies and genotype distributions of the functional PAX-6 promoter polymorphism were investigated comprising patients with DSM-IV schizophrenia, patients with affective disorders, and population controls. RESULTS No allelic or genotypic association of the PAX-6 promoter polymorphism to affective disorder or to schizophrenia as one disease entity was observed. After subtyping schizophrenia into paranoid and nonparanoid forms, potential evidence was found for a genotypic association of the high-activity variant with the paranoid subtype of schizophrenia (p = .02). The estimated odds ratio was 1.7 (95% CI .98 to 2.95) for those heterozygous and 1.4 (95% CI .82 to 2.42) for those heterozygous or homozygous for the high-activity variant compared to the homozygous low-activity variant. CONCLUSIONS Our finding indicates that early developmental genes may be involved in the etiopathogenesis of schizophrenia subtypes via variable transcriptional regulation in the developing and adult human brain.

[1]  P. Gruss,et al.  PAX genes: what's new in developmental biology and cancer? , 1995, Human molecular genetics.

[2]  P. Rashbass,et al.  Influence of PAX6 Gene Dosage on Development: Overexpression Causes Severe Eye Abnormalities , 1996, Cell.

[3]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[4]  J. Schmahmann.  An emerging concept. The cerebellar contribution to higher function. , 1991, Archives of neurology.

[5]  John P. Rice,et al.  Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: chromosomes 2, 11, 13, 14, and X. , 1997, American journal of medical genetics.

[6]  S. Easter,et al.  Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain. , 1997, Development.

[7]  F. McMahon,et al.  Evidence for a susceptibility locus for bipolar disorder on chromosome 11p11.5 , 1998 .

[8]  P. Gruss,et al.  Roles of Pax-genes in developing and adult brain as suggested by expression patterns , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  L. Siever,et al.  Genome scan of schizophrenia. , 1998, The American journal of psychiatry.

[10]  Luca Chiovato,et al.  PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis , 1998, Nature Genetics.

[11]  E. G. Jones,et al.  Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. , 1996, Archives of general psychiatry.

[12]  K. Lesch,et al.  A promoter-associated polymorphic repeat modulates PAX-6 expression in human brain. , 1998, Biochemical and biophysical research communications.

[13]  G. Edelman,et al.  Developmental control of N-CAM expression by Hox and Pax gene products. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[14]  G. Stöber,et al.  The role of maternal infectious diseases during pregnancy in the etiology of schizophrenia in offspring , 1992, European Psychiatry.

[15]  T. Magnuson,et al.  Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system , 1993, Neuron.

[16]  A. Read.  Pax genes — Paired feet in three camps , 1995, Nature Genetics.

[17]  A. Cvekl,et al.  Lens development and crystallin gene expression: many roles for Pax‐6 , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  D. Davidson,et al.  The role of Pax-6 in eye and nasal development. , 1995, Development.

[19]  Klaus-Peter Lesch,et al.  Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? , 1998, Biological Psychiatry.

[20]  Daniel R Weinberger,et al.  On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia , 1996, Neuropsychopharmacology.

[21]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[22]  S. Arnold,et al.  Further Evidence of Abnormal Cytoarchitecture of the Entorhinal Cortex in Schizophrenia Using Spatial Point Pattern Analyses , 1997, Biological Psychiatry.

[23]  K. Lesch,et al.  Regulation of PAX-6 gene transcription: alternate promoter usage in human brain. , 1998, Brain research. Molecular brain research.

[24]  G. Edelman,et al.  A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. McGlashan,et al.  Classical subtypes for schizophrenia: literature review for DSM-IV. , 1991, Schizophrenia bulletin.

[26]  J. Seltzer,et al.  A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. , 1998, Schizophrenia bulletin.

[27]  M. Akil,et al.  Cytoarchitecture of the entorhinal cortex in schizophrenia. , 1997, The American journal of psychiatry.

[28]  S. Faraone,et al.  The case for heterogeneity in the etiology of schizophrenia , 1995, Schizophrenia Research.

[29]  P. McGuffin,et al.  A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system , 1996, Psychological Medicine.

[30]  Walden Two,et al.  On the Plausibility of , 1977 .

[31]  P. Riederer,et al.  Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder , 1998, Journal of Neural Transmission.

[32]  P. Gruss,et al.  Pax-6, a murine paired box gene, is expressed in the developing CNS. , 1991, Development.

[33]  R. Maas,et al.  Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene , 1992, Nature Genetics.

[34]  M. Nakafuku,et al.  Pax-6 is involved in the specification of hindbrain motor neuron subtype. , 1997, Development.

[35]  K. Davis,et al.  The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses. , 1981, Schizophrenia bulletin.

[36]  T. Hyde,et al.  Neuropathology of the cerebellum in schizophrenia—An update: 1996 and future directions , 1997, Biological Psychiatry.

[37]  T. Matise,et al.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.

[38]  K. Lesch,et al.  Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[39]  P Gruss,et al.  Pax: gene regulators in the developing nervous system. , 1993, Journal of neurobiology.

[40]  R. Quirion,et al.  Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Weissenbach,et al.  An international two–stage genome–wide search for schizophrenia susceptibility genes , 1995, Nature Genetics.

[42]  M. Busslinger,et al.  DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5) , 1995, Molecular and cellular biology.

[43]  L. Strong,et al.  Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region , 1991, Cell.

[44]  K. Rajewsky,et al.  Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning , 1994, Nature.

[45]  J. Kelsoe,et al.  A Genetic Linkage Study of Bipolar Disorder and 13 Markers on Chromosome 11 Including the D2 Dopamine Receptor , 1993, Neuropsychopharmacology.